|
The Journal accepts manuscripts in English in the fields of Endocrinology
and Metabolism from clinical and laboratory research, with a pref erence
for experimental over observational studies. The manuscripts should not
have been published before and the author must hold the copyright (see
below). The aim of the journal is to disseminate new experimental data
in the fields of endocrinology and metabolism. With this in mind the Editors
have agreed to process manuscripts and provide detailed reviews in as
short time as possible. Correctly written manuscripts will ensure speedy
publication. The Editors reserve the right to accept manuscripts and to
make necessary corrections or shortenings, where necessary, after communicating
with the author.
Seven types of manuscripts will be accepted: 1. Original Articles, 2.
Innovative Methods, 3. Reviews, 4. Hypotheses, 5. Short Communications,
6. Symposium Proceedings, 7. Letters to the Editors.
Manuscripts
All papers should be submitted in triplicate (text: one original
and two copies; figures: two sets suitable for reproduction and one copy)
and on electronic media (preferred text processors are Microsoft
Word and Word Perfect; please include triplicate printouts as requested
above.) Illustrations and tables should be numbered with Arabic figures.
A descriptive and detailed legend is required on a separate page. Illustrations
should be professionally drawn and photographed or produced on a laser
printer. For laser-printed figures, glossy paper suitable for camera-ready
copy must be used. For each issue of Hormone and Metabolic Research a
suitable color print will be selected from the submitted work to appear
as a frontispiece. Authors are responsible for the correct typing of their
manuscript and the list of references. Nomenclature should follow the
recommendations of the International Union for Pure and Applied Chemistry
(IUPAC) and the International Union for Biochemistry (IUB). All measurements
must be in Systeme Interna tional (SI) units.
A. Original Papers
Original papers should deal with investigations and results of high scientific
value which have not been published previously.
1. The original papers should not exceed 6 printed pages, i.e. 15 type-written
double-spaced manuscript pages of 30 lines of 60 letters each, including
references, tables, figures and legends. A maximum of 4 illustrations
and 3 tables is allowed. Longer manuscripts will be subject to editing
and a page charge of 160.- per printed page (including 16% VAT) starting
with the seventh printed page.
2. Preparation of manuscripts
The authors are asked to follow the outline set out below:
Page one: a) title, b) short running title (limit: 40 characters), c)twb>
name of the author (no titles or academic grades) and address of the institute(s)
where the investigations have been carried out. Should the address of
the author at the time of publication differ from the one stated in the
paper, the current address should be stated in a footnote, d) complete
mailing address of corresponding author including telephone and telefax
numbers and e-mail addresses.
Page two: a) a summary containing not more than 200 words with no abbreviations,
b) key words (5-7 without repeating words in the title).
Page three and onwards: a) introduction also indicating the aim of the
study, b) material and methods, c) results: double presentation of data
in the form of text, tables or figures should be avoided, d) discussion
and conclusions, e) acknowledgements, f) list of references.
3. References
a) Text: Citations and references should be marked by numerical codes
in parentheses referring to the respective numbers in the List of References.
If authors are mentioned in the text, only the first author should be
given followed by "et al." whenever the ref erence has three or more authors.
Example: "...protein concentrations were determined according to Lowry
et al. [12]."
b) List of References: The references should be listed in numbered order
according to the sequence they appear in the text. All authors or groups
of authors of each publication should be mentioned. The name of the author(s)
should be followed by the full title of the paper, name of the journal
in which it has been published (abbreviations according to "World Medical
Periodicals", published by the World Medical Association), volume, first
and last page, year of publication in brackets. Abstracts and supplements
have to be indicated. Chapters from books have to be cited as follows:
author(s), title of chapter, title of book, editor(s), publisher, place
and year of publication, first and last page of the chapter.
Examples
9 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein meas urement
with the Folin-phenol reagent. J Biol Chem 1951; 193: 265-275
10 Kerner W, Pfeiffer EF. The Artificial Pancreas. In: Samols E (ed).
The Endocrine Pancreas. New York: Raven Press, 1991: 441-456
At the end of the list of references, the address of the corresponding
author should be given as follows: Requests for reprints should be addressed
to...
B. Innovative Methods
This Scientific Section will publish contributions on new aspects of
research technology deemed of particular interest to basic and clinical
researchers in the field of Endocrinology and Metabolism. Original reports
are encouraged and reviews will be solicited for publication. They should
not exceed 2 printed pages (i.e. 6 type-written double-spaced pages in
manuscript 30 lines of 60 letters each) and may include four tables and
four illustrations.
C. Reviews
Reviews are usually invited by one of the Editors-in-Chief. Unsolicited
reviews will be considered as well. All reviews will be peer-reviewed.
D. Hypotheses
Hypotheses should either formulate a new thesis on the basis of clinical
or experimental work or they should challenge a dogma in the field of
endocrinology and metabolism. They should line out relations to differing
fields of medicine.
These papers may contain preliminary data which, taken together with
previously published work in the literature, outline speculative, interesting,
and new ways of thinking in a conclusive style. The hypothesis must be
testable in future but not so easily that readers wonder why it has not
already been done. Hypotheses tend to have the length of approximately
2-3 written pages including 2 figures, the shorter - the better!
E. Short Communications
Short Communications should contain new clinical and experimental data
of immediate interest.
1. They should not exceed 2 printed pages (i.e. 6 type-written double-spaced
pages in manuscript 30 lines of 60 letters each) and may include one table
and one illustration. The list of references at the end of the paper should
not exceed ten citations. The publisher will impose a page charge of
160.- per printed page (including 16% VAT) starting with the third page.
2. The guidelines for the structure of Short Communications are the same
as for Original Papers with following exceptions: a) no summary, b) no
key words, c) no titles of the papers in the list of references.
F. Symposium Proceedings
Symposium proceedings are usually invited. However, organisers of symposia
are encouraged to contact one of the Editors.
G. Commentaries
Commentaries are usually invited. They aim at commenting on subjects
with a strong impact upon experimental endocrinology and metabolism.
continued on inside back cover
Continuation from inside front cover
H. Letters to the Editors This section has been introduced in
order to encourage the authors in a free exchange of ideas. The opinions
presented will not necessarily reflect the opinions of the Editors. Authors
will be immediately notified of the receipt and they will be notified
within two months of the decision on their manuscript.
Electronic Manuscripts
Whenever possible, manuscripts should be made available electro nically.
Widespread text processors should be used and the operating system, programme
and version numbers should be indicated on the diskette. Please save your
file in the standard format of your text processor and in one or several
exchange format/s (for example, *.txt, *.rtf). If possible, the "endnote"
function of the text processor should be used for the management of references.
Figure legends and tables should be listed at the end of the document.
Please save figures as separate files. They should not be integrated
into the text document. The following graphic file formats are preferred:
- For coloured and black-and-white bitmaps: *.eps, *.tif, *.jpg, *.wmf
(resolution: 300 dpi).
- For diagrams and line drawings: *.eps (resolution: 800 dpi).
In addition to the electronic files, three paper versions of both text
and figures must be submitted. In case of doubt, the paper version is
given the higher priority.
Please provide a signed declaration that the paper and electronic versions
are identical.
Reprints
The publisher grants 25 reprints free of charge. Additional copies may
be ordered at cost price.
Copyright
The publisher holds the copyright on all material appearing in the Journal.
Manuscript submission
All papers are critically reviewed by the Editors and invited referees.
Reviewers' comments are usually returned to the authors. Please include
the names of at least three potential reviewers (not recent co-authors
or collaborators) together with their complete addresses, telephone and
fax numbers as well as email addresses.
Reviews should be sent to the Editors-in-Chief.
Original articles and Short Communications should be submitted
to the Editors-in-Chief. All manuscripts for
the section Innovative Methods should be submitted to the Editor Innovative
Methods.
Editors-in-Chief:
Werner A. Scherbaum, M.D., Ph.D.
Director and Chair
Department of Endocrinology,
Diabetes and Rheumatology
University Hospital Düsseldorf
Moorenstrasse 5
40225 Düsseldorf, Germany
Phone: (+49) 211-81 18 502
Fax: (+49) 211-81 18 772
E-mail: hmr@thieme.de
Assistant Editor:
Matthias Schott, M.D.
Department of Endocrinology,
Diabetes and Rheumatology
University Hospital Düsseldorf
Moorenstrasse 5
40225 Düsseldorf, Germany
Phone: (+49) 211-81 17 810
Fax: (+49) 211-81 17 860
E-mail: schottmt@uni-duesseldorf.de
Associate Editors:
H. Vaudry, M.D.
Regional Editor Europe
European Institute for Peptide Research
Laboratory of Cellular and
Molecular Neuroendocrinology
Inserm U 413; UA CNRS
University of Rouen
76821 Mont-Saint-Aignan, France
Phone: (+33) 235146624
Fax: (+33) 235146946
E-mail: hubert.vaudry@univ-rouen.fr
Derek LeRoith, M.D., Ph.D. (Editor Innovative Methods)
Chief of the Division of Endocrinology and Diabetes
Dept. Medicine
The Mount Sinai School of Medicine
One Gustave L. Levy Place, Box 1055
Annenberg Building Room 23–66 B
New York, NY 10029-6574
Phone: (+1)212 241 0160
Fax: (+1)212 241 4218
E-mail: derek.leroith@mssm.edu
Stefan R. Bornstein, M.D., Ph.D.
Director and Chair
Endocrinology, Diabetes and Metabolism
Department of Medicine
Carl Gustav Carus
University of Dresden
Fetscherstrasse 74
01307 Dresden, Germany
Phone: (+49)351-458-59 55
Fax: (+49)351-4 58-63 98
E-mail: stefan.bornstein@uniklinikum-dresden.de
|